Results 91 to 100 of about 5,756 (158)

HCN2 channels: a potential therapeutic target for orofacial neuropathic pain after trigeminal nerve injury. [PDF]

J Oral Facial Pain Headache
Yamamoto T, Ujita T, Sato-Yamada Y, Ichiki T, Kishimoto N, Terunuma M, Seo K.   +6 more
europepmc   +1 more source

Optimal Heart Rate Modulation Therapy Using Ivabradine in Individuals With Acute Heart Failure. [PDF]

Clin Cardiol
Kataoka N, Imamura T.
europepmc   +1 more source

Improvement of cardiac function by Ivabradine in a doxorubicin-induced cardiomyopathy murine model is associated with a normal renal angiotensin II type I receptor expression but not with a reduction in fibrosis. [PDF]

Cardiooncology
Drumeva GO, Plane AF, Petrenyov DR, Ribeiro PAB, Chen C, DaSilva JN, Tournoux FB.   +6 more
europepmc   +1 more source

Comparative Effectiveness of Ivabradine versus Digoxin in Patients with Heart Failure with Reduced Ejection Fraction and Chronic Kidney Disease: A Real-World Multicenter Cohort Study.

Cardiorenal Med
Wu JY, Lee KW, Huang SC, Chang HY, Lin YM.   +4 more
europepmc   +1 more source

Efficacy of ivabradine in heart rate reduction after cardiac transplantation: Systematic review and meta-analysis. [PDF]

World J Cardiol
Ahmed F, Ali R, Haider F, Shah HH, Farhan K, Jahangir K, Kiyani M, Khan MS, Afzaal Z, Khan SI, Nizam MA, Usman M, Gohar N, Ahmed M, Mirza TR, Sattar Y, Taha A, Almendral J, Alenezi F.   +18 more
europepmc   +1 more source

Successful Treatment With Ivabradine for Junctional Ectopic Tachycardia-Induced Cardiomyopathy With Hypoplastic Left Heart Syndrome. [PDF]

J Arrhythm
Fukuda Y, Aoki H, Takigiku K, Inamura N.
europepmc   +1 more source

Heart rate management using ivabradine in acute myocardial infarction: a propensity score-matched single-center study. [PDF]

Sci Rep
Chen M, Zhong P, Li C, Gao Q, Luo Z, Gu D.   +5 more
europepmc   +1 more source

Ivabradine, atrial fibrillation and stroke: a combined meta-analysis and FAERS disproportionality analysis. [PDF]

Front Pharmacol
Spadotto A, Fusaroli M, Carelli M, Nardi E, Amadori M, Massaro G, De Angelis V, Gatti M, Ciubine V, Raschi E, Poluzzi E, Diemberger I.   +11 more
europepmc   +1 more source

Novel drugs targeting genetic variants: current applications and future prospects in heart failure treatment. [PDF]

Front Mol Biosci
Li X, Bai S, Luo Y.
europepmc   +1 more source

Ivabradine for anthracycline-induced cardiotoxicity: emerging promise and current evidence. [PDF]

Ann Med Surg (Lond)
Wasti SA, Wasti A, Berkinbayeva M, Iqbal MU, Danaf N.   +4 more
europepmc   +1 more source